Medicale Corp. financial data

Symbol
MCLE on OTC
Location
9314 Forest Hill Blvd, #929, Wellington, FL
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2025 - Aug 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.34 % -56.6%
Debt-to-equity -100 % +0.18%
Return On Equity 40.5 % -53.7%
Return On Assets -59.6K % -70.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.92M shares 0%
Common Stock, Shares, Outstanding 5.92M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 592 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5.92M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 5.92M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 40.3K USD -24.5%
Operating Income (Loss) -40.3K USD +24.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -58.2K USD -54.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -47.4K USD +14.8%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 0 USD -100%
Assets 0 USD -100%
Accounts Payable, Current 995 USD
Accrued Liabilities, Current 5.19K USD
Liabilities, Current 29.4K USD +108%
Liabilities 129K USD +57.4%
Retained Earnings (Accumulated Deficit) -206K USD -29.8%
Stockholders' Equity Attributable to Parent -129K USD -57.7%
Liabilities and Equity 0 USD -100%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10K USD +63.9%
Net Cash Provided by (Used in) Financing Activities 10K USD -63.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 5.92M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 USD -100%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 36.9K USD +49.5%
Deferred Tax Assets, Operating Loss Carryforwards 36.9K USD +49.5%
Additional Paid in Capital 76.3K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD